Dr. Travis recalls the new oral medications that will be used to treat multiple sclerosis (MS) and describes why some MS patients have difficulty walking.
There are several new medications that are being researched for MS or multiple sclerosis that come in oral form. Several to mention would be Fingolimod, Cladribine, Laquinimod and Teriflunomide and dimethyl fumarate.
The reason why is because multiple sclerosis or MS affects the nerve fibers as they exit from the brain and go through the spinal cord, and if those nerve fibers are affected along their course they can interfere with your ability to move your arms or legs and ability to walk.
So the myelin sheath is the lining around the nerve fiber and what it can be thought of is the insulation around the nerve fiber. In multiple sclerosis, that myelin sheath is attacked by the body and so the nerves can’t conduct their impulses as well.
About Dr. Lori Travis, M.D.:
Dr. Travis is a graduate of the University of Arizona Medical School. She completed her neurology residency at The Mayo Clinic in Rochester, Minnesota where she was elected Chief Resident. Dr. Travis is board certified by the American Board of Psychiatry and Neurology. She is currently on faculty at the University of Arizona as a Clinical Assistant Professor of Neurology.